Product and clinical questions

Preparation, use, safety and procurement answers for professional teams.

An MPad™ cooling unit being inserted into a CarbonCool® holder

01 / Answers

Questions by topic

Product and technology

How does CarbonCool® differ from ice packs?

HypoCarbon® is specified at 35 W/mK, compared with 2.3 W/mK for frozen water. The 15× figure compares material conductivity, not clinical cooling rate. In the Full Body Suit™, frozen MPads are positioned at the torso and thighs.

How long do MPads stay ready for use?

The prepared system can remain operationally ready in the CarbonCool® Bag for up to 12 hours. This is transport readiness, not continuous treatment duration. For longer treatment, replace MPads with freshly frozen units according to protocol.

Can the system be used with cardiac monitoring or defibrillation?

Plan pad placement and chest access within the clinical protocol, and follow the instructions for every device in use. Contact the clinical support team when validating a local workflow.

Clinical use

Can CarbonCool® be used during patient transport?

The portable system can remain on the patient during field or hospital transport. MPads must be frozen before deployment, no electricity is required during cooling, and core temperature requires a separate appropriate monitoring device.

What does the published research report?

Published CarbonCool research includes heat-stroke case reports and a 124-patient emergency-department cohort using a combined cooling protocol. Among patients with available cooling-time data in that cohort, median time from return of spontaneous circulation to 34°C was 119 minutes in 22 patients receiving the protocol incorporating CarbonCool, compared with 482 minutes in 39 historical controls. Survival and neurological outcomes did not differ significantly. Results depend on the starting temperature, patient and protocol; the research library identifies each configuration and study design. Source: Yap et al., 2020.

What are the contraindications?

The instructions for use list: Skin diseases, Bedsore, Inflammation, Burns or other skin injuries. Additional precautions apply, including skin checks and appropriate core temperature monitoring. Review the complete safety information before use.

Procurement

What regulatory clearances does CarbonCool® have?

CarbonCool® is registered or cleared in 10 markets, including the United States (FDA 510(k)) and the European Union (CE, MDR). See the Regulatory page for each market and its identifiers.

How should we assess total cost of ownership?

Include the suit, MPads and holders, freezer preparation, training and replacement planning. Cooling itself needs no electricity or ice, and the system has no mechanical maintenance. Request a facility-specific comparison rather than relying on a generic saving estimate.

What training is required?

CarbonCool® is for trained medical personnel. Training should cover sizing, application, frozen MPad handling, skin checks, core temperature monitoring, cleaning and the local clinical protocol. Contact support to plan product education.

Continue the conversation

Still have a question? Request a consultation with our team.

Request a consultation